A prefabricated device made of orthopaedic bone cement [e.g., polymethylmethacrylate (PMMA)], with an appropriate antibiotic, that is temporarily placed into a joint space to function as a carrier for the local delivery of antibiotic drugs and to prevent bone-
| Company | Devices | Share |
|---|---|---|
| Osteoremedies, Llc | 80 | 28% |
| Biomet Orthopedics, Llc | 78 | 27% |
| Howmedica Osteonics Corp. | 44 | 15% |
| Tecres Spa | 28 | 10% |
| Biocomposites Ltd | 24 | 8% |
| Heraeus Medical Gmbh | 13 | 5% |
| Microport Orthopedics Inc. | 13 | 5% |
| G21 Srl | 4 | 1% |
Company = labeler of record on GUDID. 8 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| MBB | Bone Cement, Antibiotic | 69 |
| KWL | Prosthesis, Hip, Hemi-, Femoral, Metal | 65 |
| LZO | Prosthesis, hip, semi-constrained, metal/ceramic/polymer, ce | 60 |
| KWY | Prosthesis, Hip, Hemi-, Femoral, Metal/Polymer, Cemented Or | 56 |
| JDI | Prosthesis, hip, semi-constrained, metal/polymer, cemented | 43 |
| JWH | Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cem | 41 |
Use these as the dimensions to specify in a tender line.
284 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Orthopaedic cement spacer", from 8 companies. The largest labeler is Osteoremedies, Llc with 28% of records.
MBB (Bone Cement, Antibiotic), KWL (Prosthesis, Hip, Hemi-, Femoral, Metal), LZO (Prosthesis, hip, semi-constrained, metal/ceramic/polymer, ce), KWY (Prosthesis, Hip, Hemi-, Femoral, Metal/Polymer, Cemented Or )
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add orthopaedic cement spacer to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.